Spencer Cash Conversion Cycle from 2010 to 2025
| SPPH Stock | USD 0.0001 0.00 0.00% |
Cash Conversion Cycle | First Reported 2010-12-31 | Previous Quarter 0.048 | Current Value 0.0456 | Quarterly Volatility 42.23279563 |
Check Spencer Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spencer Pharmaceutical's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 754.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0. Spencer financial statements analysis is a perfect complement when working with Spencer Pharmaceutical Valuation or Volatility modules.
Spencer | Cash Conversion Cycle | Build AI portfolio with Spencer Stock |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out the analysis of Spencer Pharmaceutical Correlation against competitors. For more detail on how to invest in Spencer Stock please use our How to Invest in Spencer Pharmaceutical guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spencer Pharmaceutical. If investors know Spencer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spencer Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Spencer Pharmaceutical is measured differently than its book value, which is the value of Spencer that is recorded on the company's balance sheet. Investors also form their own opinion of Spencer Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Spencer Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spencer Pharmaceutical's market value can be influenced by many factors that don't directly affect Spencer Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spencer Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spencer Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spencer Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.